NRL-011 - NEUROTECHNOLOGY - Upcoming
Blindsight Vision Restoration Trials
Early trials of direct visual cortex stimulation to restore sight.
Part of Neuralink→OVERVIEW
Early trials of direct visual cortex stimulation to restore sight.
FUNDING PROGRESS
20%$9,000,000 raised of $45,000,000 goal
MISSION DETAILS
- Venture
- Neuralink
- Sector
- Neurotechnology
- Status
- Upcoming
INVEST IN BLINDSIGHT VISION RESTORATION TRIALS
Neuralink · NRL-011
$40.0k – $60k
·10% DAILY ROI
$40.0k$60k
SELECTED - $40.0k